Indian Army Pharmaceutical Product Supply for Respiratory and Other Essential Medications

This tender, issued by the Department of Military Affairs under the Ministry of Defence for the Indian Army, seeks the supply of essential pharmaceutical products. The Bid Number is GEM/2026/B/8134000, with bidding commencing on 22-10-2026 at 11:56 AM and concluding on 05-11-2026 at 12:00 PM. The Bill of Quantities (BOQ) encompasses a diverse range of critical medications under the title "CDL DRUGS," including respiratory solutions and inhalers such as Ipratropium Bromide Respirator Soln 500mcg per 2ml Respule, Salmeterol 50 mcg plus Fluticasone 500 mcg Accuhaler, Tiotropium Bromide 18 mcg rotacap, Formoterol 6 mcg and Budesonide 200 mcg Inhaler, Salmeterol 25 mcg plus Fluticasone 250mcg Autohaler, and Salmeterol 25 mcg plus Fluticasone 125 mg MDI. The tender also includes various tablets for different therapeutic needs, such as Methylprednisolone (4 mg and 8 mg), Deflazacort 6mg, Prednisolone 10 mg, Linezolid 600 mg, Carbimazole (20 mg and 5 mg), Metformin SR 1 gm, Thyroxine Sodium (0.1 mg, 0.025 mg, 50 mcg, 75mcg), Voglibose 0.3mg, Dutasteride 0.5 mg, and Ethinyl Estradiol 0.035mg and Cyproterone Acetate 2mg. Additionally, nutritional supplements like Power Dextrose monohydrate for oral use (pkt of 500 gm) and Evening Primrose oil 500 mg Cap are required. The total quantity of items to be supplied is 2,163,376. This procurement is essential for the medical well-being of personnel associated with the Indian Army.